Kaposi sarcoma trends in Uganda and Zimbabwe: A sustained decline in incidence?

International Journal of Cancer

Volumn 133, Issue 5, 2013, Pages 1197-1203

  Chaabna, Karima ^a   Bray, Freddie ^a   Wabinga, Henry R ^b   Chokunonga, Eric ^c   Borok, Margaret ^c   Vanhems, Philippe ^d,e   Forman, David ^a   Soerjomataram, Isabelle ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b MAKERERE UNIVERSITY   (Uganda)

^c Andrew Fleming Hospital   (Zimbabwe)

^d EDOUARD HERRIOT HOSPITAL   (France)

^e UNIVERSITÉ LYON 1   (France)

Author keywords

HIV; Kaposi sarcoma; time trends; Uganda; Zimbabwe

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BIRTH; CANCER INCIDENCE; CANCER REGISTRY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; EPIDEMIC; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; NEWBORN; POPULATION RESEARCH; PRESCHOOL CHILD; PREVENTIVE MEDICINE; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; TREND STUDY; UGANDA; ZIMBABWE;

HIV; KAPOSI SARCOMA; TIME TRENDS; UGANDA; ZIMBABWE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SARCOMA, KAPOSI; SEX CHARACTERISTICS; TIME FACTORS; UGANDA; ZIMBABWE;

EID: 84879246539     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28125     Document Type: Article

References (45)

1. Taylor JF, Templeton AC, Vogel CL, et al. Kaposi's sarcoma in Uganda: a clinico-pathological study. Int J Cancer 1971; 8: 122-35.
2. Thijs A,. Kaposi's angiosarcomatosis in the Belgian Congo & Ruanda-Urundi. Ann Soc Belg Med Trop (1920) 1957; 37: 295-308.
3. Cook-Mozaffari P, Newton R, Beral V, et al. The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer 1998; 78: 1521-8.
4. Shiels MS, Pfeiffer RM, Hall HI, et al. Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. JAMA 2011; 305: 1450-9.
5. Seaberg EC, Wiley D, Martinez-Maza O, et al. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Cancer 2010; 116: 5507-16.
6. Green EC, Halperin DT, Nantulya V, et al. Uganda's HIV prevention success: the role of sexual behavior change and the national response. AIDS Behav 2006; 10: 335-46.
7. Halperin DT, Mugurungi O, Hallett TB, et al. A surprising prevention success: why did the HIV epidemic decline in Zimbabwe? PLoS Med 2011; 8: e1000414.
8. Franceschi S, Lise M, Clifford GM, et al. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer 2010; 103: 416-22.
9. WHO. Progress on global access to HIV antiretroviral therapy: a report on "3 by 5" and beyond. Geneva, Swizerland: WHO, 2006.
10. Sanders CJ,. Kaposi's sarcoma in retrospect. Genitourin Med 1997; 73: 571-74.
11. Parkin DM, Wabinga H, Nambooze S, et al. AIDS-related cancers in Africa: maturation of the epidemic in Uganda. AIDS 1999; 13: 2563-70.
12. UNAIDS, WHO. 2008 Report on the global AIDS epidemic. UNAIDS WHO 2010 [cited 2010]; Available from: URL: http://www.unaids.org/en/KnowledgeCentre/ HIVData/GlobalReport/2008/2008-Global-report.asp.
13. Fritz A, Pajares JM, Jack A, et al. International classification of diseases for oncology, 3rd ed. Geneva, Swizerland: WHO, 2000.
14. Parkin DM, Vizcaino AP, Skinner ME, et al. Cancer patterns and risk factors in the African population of southwestern Zimbabwe, 1963-1977. Cancer Epidemiol Biomarkers Prev 1994; 3: 537-47.
15. Chokunonga E, Levy LM, Bassett MT, et al. Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993-1995. Int J Cancer 2000; 85: 54-9.
16. Wabinga H, Nambooze S, Amulen M,. Uganda, Kampala Cancer Registry (KCR) 2008. Kampala Cancer Registry 2010 [cited 2010 Dec 1]; Available from: URL: http://www.breastcancerafrica.org/documents/information/kampala-cancer-registry. doc.
17. CI5 I-IX Cancer Incidence in Five Continents Volumes I to IX. IARC 2012 [cited 2012 Jul]; Available from: URL: http://ci5.iarc.fr/CI5i-ix/ci5i-ix.htm.
18. Curado MP, Edwards B, Shin HR, et al. Cancer Incidence in five continents. Lyon: IARC, 2008.
19. Dos Santos Silva I,. Cancer epidemiology: principles and methods. Lyon, France: IARC, 1999.
20. Šidàk Z,. Rectangular confidence region for themeans of multivariate normal distributions. J Am Statis Asso 1967; 62: 626-33.
21. Statistical Research and Applications Branch. Joinpoint Regression Program. In: National Cancer Institute, ed. Bethesda, MD: National Cancer Institute, 2008.
22. Clegg LX, Hankey BF, Tiwari R, et al. Estimating average annual per cent change in trend analysis. Stat Med 2009; 28: 3670-82.
23. JoinPoint Regression Program [computer program]. Version 3.5 Surveillance Research Program National Cancer Institute; 2011.
24. Sissolak G, Mayaud P,. AIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa. Trop Med Int Health 2005; 10: 981-92.
25. Serwadda D, Mugerwa RD, Sewankambo NK, et al. Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet 1985; 2: 849-52.
26. Okware SI,. Towards a national AIDS-control program in Uganda. West J Med 1987; 147: 726-9.
27. Hiza PR., International co-operation in the national AIDS control program. In: Fleming A, ed. Proceeding of the First International Conference on the Global Impact of AIDS. New York, USA, 2010. 233-9.
28. UNAIDS WHO. UNAIDS report on the global AIDS epidemic 2010. Geneva, Swizerland; 2010.
29. Vanni T, Sprinz E, Machado MW, et al. Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives. Cancer Treat Rev 2006; 32: 445-55.
30. Mosam A, Uldrick TS, Shaik F, et al. An evaluation of the early effects of a combination antiretroviral therapy programme on the management of AIDS-associated Kaposi's sarcoma in KwaZulu-Natal, South Africa. Int J STD AIDS 2011; 22: 671-3.
31. Mosam A, Shaik F, Uldrick TS, et al. A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa. J Acquir Immune Defic Syndr 2012; 60: 1507.
32. UNAIDS/WHO. UNAIDS World AIDS Day Report 2011. Geneva, Swizerland: UNAIDS/WHO; 2011.
33. Stoneburner RL, Low-Beer D,. Population-level HIV declines and behavioral risk avoidance in Uganda. Science 2004; 304: 714-8.
34. Shelton JD, Halperin DT, Nantulya V, et al. Partner reduction is crucial for balanced "ABC" approach to HIV prevention. BMJ 2004; 328: 891-3.
35. Cohen S,. Promoting the "B" in ABC: its value and limitations in fostering reproductive health. The Guttmacher Report on Public Policy; 2004 Oct 1, vol. 7, p. 4.
36. Fenton L,. Preventing HIV/AIDS through poverty reduction: the only sustainable solution? Lancet 2004; 364: 1186-7.
37. Singh S, Darroch JE, Bankole A., A, B and C in Uganda: the roles of abstinence, monogamy and condom use in HIV Decline. Occasional Report No. 9. New York: Allan Guttmacher Inst, 2003.
38. International Programs Center PDUSCB. HIV/AIDS Surveillance Data Base: Uganda. International Programs Center,Population Division, U S Census Bureau 2000 June [cited 2010 Dec 1]; Available from: URL: http://www.census.gov/ipc/ hiv/uganda08.pdf.
39. Biryahwaho B, Dollard SC, Pfeiffer RM, et al. Sex and geographic patterns of human herpesvirus 8 infection in a nationally representative population-based sample in Uganda. J Infect Dis 2010; 202: 1347-53.
40. Dollard SC, Butler LM, Jones AM, et al. Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt". Int J Cancer 2010; 127: 2395-401.
41. Pfeiffer RM, Wheeler WA, Mbisa G, et al. Geographic heterogeneity of prevalence of the human herpesvirus 8 in sub-Saharan Africa: clues about etiology. Ann Epidemiol 2010; 20: 958-63.
42. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-9.
43. IARC. International Agency for Research on Cancer (IARC). Kaposi's sarcoma herpesvirus/human herpes virus 8. Lyon, France: IARC, 1997.
44. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens - Part B: biological agents. Lancet Oncol 2009; 10: 321-2.
45. Safai B, Mike V, Giraldo G, et al. Association of Kaposi's sarcoma with second primary malignancies: possible etiopathogenic implications. Cancer 1980; 45: 1472-9.